2023: The Year of OCE — Crucial for Pharma’s Success
HCP satisfaction with biopharma digital offerings is slowly increasing. That’s the good news. The bad news? More than half of HCPs remain dissatisfied or neutral with pharma’s digital offerings. There is room for improvement. Omnichannel engagement (OCE) can help.